The severe asthma treatment market is experiencing robust expansion, driven by rising disease prevalence, improved diagnostic approaches, and breakthrough therapeutic developments from key ...

Eli Lilly will acquire gene-editing startup Verve Therapeutics for up to $1.3 billion, the companies said on Tuesday, to ...

ANGLE presents new data at EACR 2025 DEMONSTRATING DNA DUAL ANALYSIS FOR COMPREHENSIVE LIQUID BIOPSY PROFILING Poster highlights ANGLE's combined CTC-DNA and ctDNA analysis revealing tumour ...

AstraZeneca, Pfizer and more are leveraging the computational power of AI to better design trials, predict the potential ...

Neoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with chemotherapy alone for patients with resectable non-small cell lung cancer (NSCLC), the ...

AstraZeneca has presented results for the SERENA-6 trial at the American Society for Medical Oncology (ASMO)'s 2025 conference, held in Chicago, Illinois from 30 May to 3 June. The SERENA-6 trial ...

A trial funded by AstraZeneca found the drug is effective in stopping cancer cells from using hormones to grow ...

Breast cancer patients whose tumors have spread to other parts of their bodies live from scan to scan. Is their treatment working? Or will they learn their cancer is growing again? But a new study ...

Data from the study, which AstraZeneca funded and in February said succeeded ... accomplished by using “liquid biopsies,” tests that pick up fragments of tumor DNA circulating in the blood. While ...

A new drug can help stop certain breast cancer tumours before they grow, experts say. A trial called Serena-6 shows that camizestrant stops cancer cells from using hormones to grow, which helps ...